Looks like all of the sales were option exercise and immediate sale - so they weren't selling down existing holdings, they just had next-to-no ownership to start with.
Any comments here may have previously been disseminated on Twitter @BioDueDiligence or at www.biotechduediligence.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.